FDA NDC Directory · JSON-LD · Markdown

MONTELUKAST SODIUM

NDC 27241-015 · HUMAN PRESCRIPTION DRUG · GRANULE

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203438
Dosage form / routeGRANULE · ORAL
Active ingredientsMONTELUKAST SODIUM (4 mg/1)
Marketing started20150813
Package count1

External sources

Source: openFDA. Public-domain (CC0).